Table 3.
LUNG | MV | HFNV |
---|---|---|
| ||
Alveolization/Septal formation | Decreased | Increased |
Mesenchymal apoptosis | Decreased | Increased |
PTHrP-PPAR-γ pathway | No change | Enhanced |
Angiogenic pathways | Decreased | Increased |
IGF-1 | Increased | Decreased |
TLR-4 | Increased | Decreased |
VASP | Increased | Decreased |
Histone acetylation | Decreased | Increased |
| ||
BRAIN | ||
| ||
Reactive gliosis/astrocytosis | Increased | Decreased |
Glial/neuronal apoptosis | Increased | Decreased |
Angiogenic pathways | Decreased | Increased |
IGF-1 | Decreased | Increased |
TLR-4 | Increased | Decreased |
BDNF | Decreased | Increased |
Histone acetylation | Decreased | Increased |
PTHrP-PPAR-γ = Parathyroid Hormone-related Protein-Peroxisome Proliferator-Activated Receptor γ; IGF = insulin-like growth factor; TLR = toll-like receptor; VASP = vasodilator-activated phosphoprotein (stretch mediated regulator of epithelial actin-cytoskeletal remodeling); BDNF = brain derived neurotrophic factor